These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 3180302

  • 21. Helicobacter pylori and the risk of benign and malignant biliary tract disease.
    Bulajic M, Maisonneuve P, Schneider-Brachert W, Müller P, Reischl U, Stimec B, Lehn N, Lowenfels AB, Löhr M.
    Cancer; 2002 Nov 01; 95(9):1946-53. PubMed ID: 12404289
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of cefepime in bile and gall bladder tissue after prophylactic administration in patients with extrahepatic biliary diseases.
    Petrikkos G, Kastanakis M, Markogiannakis A, Kastanakis S, Bastounis E, Antonios P, Daikos GL, Katsilambros N.
    Int J Antimicrob Agents; 2006 Apr 01; 27(4):331-4. PubMed ID: 16563705
    [Abstract] [Full Text] [Related]

  • 23. [Concentrations of aminosidine in human choledochal bile after a single intramuscular injection].
    Calabi V, Curcio L, Schioppacassi G.
    Atti Accad Med Lomb; 1975 Apr 01; 30(1-3):17-24. PubMed ID: 1234848
    [No Abstract] [Full Text] [Related]

  • 24. [Preoperative biliary culture and short-term antibiotic therapy].
    Guzzetti A.
    Chir Ital; 1984 Jun 01; 36(3):408-11. PubMed ID: 6525700
    [Abstract] [Full Text] [Related]

  • 25. Treatment of bacterial peritonitis.
    Puleo S, Scilletta B, Guastella T, Licata A, Nicoletti G, Rodolico G.
    Chemioterapia; 1988 Aug 01; 7(4):241-4. PubMed ID: 3180304
    [Abstract] [Full Text] [Related]

  • 26. [Chemotherapy on the biliary tract infections. XIII. Miloxacin, a novel chemotherapeutic agent, its excretion into bile and clinical effect on the biliary tract infections (author's transl)].
    Jpn J Antibiot; 1981 Sep 01; 34(9):1335-52. PubMed ID: 7328756
    [Abstract] [Full Text] [Related]

  • 27. Prevention of urinary tract infections in elderly diabetic patients with cefotetan.
    Romanelli G, Giustina A, Cravarezza P, Zuccato F, Ravizzola G, Turano A.
    J Chemother; 1989 Jul 01; 1(4 Suppl):1013-4. PubMed ID: 16312749
    [No Abstract] [Full Text] [Related]

  • 28. Cefotetan versus cefoxitin in the treatment of patients with biliary sepsis assessed by a biliary sepsis score.
    Basoli A, Schietroma M, Fiocca F, Vigliardi G, Speranza V.
    J Chemother; 1989 Jul 01; 1(4 Suppl):825-7. PubMed ID: 16312657
    [No Abstract] [Full Text] [Related]

  • 29. High biliary elimination of ceftriaxone in man.
    Brogard JM, Blickle JF, Jehl F, Arnaud JP, Paris-Bockel D, Monteil H.
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr 01; 26(4):167-72. PubMed ID: 3403093
    [Abstract] [Full Text] [Related]

  • 30. Activities of cefoxitin in vitro and in vivo: a study in patients with biliary tract infection undergoing percutaneous transhepatic biliary drainage.
    Masuda G, Tabata I, Isawa T, Yamazaki E, Mizuoka K.
    Methods Find Exp Clin Pharmacol; 1986 Jun 01; 8(6):367-72. PubMed ID: 3526054
    [Abstract] [Full Text] [Related]

  • 31. [Effectiveness of cefotetan in clinical practice].
    Vinogradova MA, Kozko TD, Petukhov EM, Shubina VA, Shneĭter II, Miroshina TI, Vinogradov NA, Astaf'eva TA, Astakhova ZN, Bokov IB, Rogovaia KI, Maksimova VI, Petrushina VS, Predtechenskaia TI.
    Antibiot Khimioter; 1997 Jun 01; 42(7):16-9. PubMed ID: 9334142
    [Abstract] [Full Text] [Related]

  • 32. The pharmacokinetic properties of cefotetan and its relevance for prophylaxis in elective colorectal surgery.
    Kujath P, Düsel W, Bruch HP, Kees F.
    J Chemother; 1989 Jul 01; 1(4 Suppl):1002-4. PubMed ID: 16312743
    [No Abstract] [Full Text] [Related]

  • 33. [Tissue penetration of single-dose cefotetan used for antibiotic prophylaxis in colorectal surgery].
    Martin C, Mallet MN, Lambert D, Brun JP, Yrieix C, Bruguerolle D, Sastre B.
    Pathol Biol (Paris); 1990 Jun 01; 38(5 ( Pt 2)):500-3. PubMed ID: 2143572
    [Abstract] [Full Text] [Related]

  • 34. Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.
    Nix DE, Sands MF, Peloquin CA, Vari AJ, Cumbo TJ, Vance JW, Fracasso JE, Schentag JJ.
    Am J Med; 1987 Apr 27; 82(4A):352-6. PubMed ID: 3555060
    [Abstract] [Full Text] [Related]

  • 35. [Current trends in surgical infections of the gallbladder and bile ducts].
    Guzzetti A, Premoli P.
    Chir Ital; 1982 Apr 27; 34(2):196-224. PubMed ID: 7046970
    [No Abstract] [Full Text] [Related]

  • 36. Cefotetan monotherapy in the treatment of intra-abdominal infection.
    Pfeiffer M.
    Chemioterapia; 1987 Jun 27; 6(2 Suppl):472-4. PubMed ID: 3509475
    [No Abstract] [Full Text] [Related]

  • 37. [Multicenter study of cefoperazone in Austria].
    Forenbacher HH.
    Wien Med Wochenschr; 1985 Mar 15; 135(5):123-6. PubMed ID: 3993050
    [Abstract] [Full Text] [Related]

  • 38. A controlled study of cefotetan versus cefotaxime in the treatment of acute infections.
    Schmidt G, Lossnitzer K.
    Chemioterapia; 1987 Jun 15; 6(2 Suppl):371-2. PubMed ID: 3334578
    [No Abstract] [Full Text] [Related]

  • 39. Antibiotic prophylaxis in high-risk biliary tract surgery: a comparison of mezlocillin and cefotetan. Preliminary results.
    De Nunno T, Savio S, Castelli A, Alegente G, De Lalla F.
    J Chemother; 1989 Jul 15; 1(4 Suppl):979-80. PubMed ID: 16312732
    [No Abstract] [Full Text] [Related]

  • 40. Clinical trials with cefoperazone in the field of internal medicine in Japan.
    Mashimo K, Kunii O.
    Clin Ther; 1980 Jul 15; 3(Spec Issue):159-72. PubMed ID: 6446392
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.